Difference between revisions of "Salivary glands"

Jump to navigation Jump to search
(+molecular)
Line 537: Line 537:


==Salivary duct carcinoma==
==Salivary duct carcinoma==
Needs work.
===General===
*Malignant counterpart of ''salivary duct adenoma''.
*Male:female ~= 4:1.
*Typically >50 years old.
*Mostly in the parotid.
 
===Microscopic===
Features:
*Architecture: sheets, nests, cords, cribriform, micropapillary.
*Neoplastic cells line-up around cystic spaces "Roman bridges".
*Nuclear atypia (variation in size, shape, staining).
*Apocrine snouts - pseudopod-like/lollipop-like undulations of the cell membrane.
*Decapitation secretions - apocrine snouts (membrane bound blobs of cytoplasm) that have separated from its mother cell.
 
Image:
*[http://www.webpathology.com/image.asp?case=122&n=2 Salivary duct carcinoma (webpathology.com)].


*Malignant counterpart of ''salivary duct adenoma''.
Notes:
*Similar to ductal breast carcinoma.
 
====Subtypes====
*Conventional.
*Mucinous - worse prognosis; opposite of what would one expect from the outcomes in [[breast cancer]].
*Micropapillary - assoc. with a poor prognosis.
*Sarcomatoid/spindle cell.
 
===IHC===
*LMWK, EMA, CK7, CK19 +ve.
*p63 -ve.
*Androgen receptor +ve.
*BRST2 (GCDFP-15) +ve.
*HER2 +ve ~21%; use of trastuzumab (Herceptin) not systematically studied.
 
Curiosity:
*PSA +/-.
*PSAP +/-.


==Polymorphous low-grade adenocarcinoma==
==Polymorphous low-grade adenocarcinoma==